-
Taxonomy & unit
-
us-gaap: shares
-
Description
-
The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.
-
Summary
-
Guided Therapeutics Inc quarterly/annual Weighted Average Number of Shares Outstanding, Diluted history and growth rate from 2017 to 2024.
- Guided Therapeutics Inc Weighted Average Number of Shares Outstanding, Diluted for the quarter ending December 31, 2024 was 57.3K shares, a 12.1% increase year-over-year.
- Guided Therapeutics Inc annual Weighted Average Number of Shares Outstanding, Diluted for 2024 was 57.3K shares, a 12.1% increase from 2023.
- Guided Therapeutics Inc annual Weighted Average Number of Shares Outstanding, Diluted for 2023 was 51.1K shares.
- Guided Therapeutics Inc annual Weighted Average Number of Shares Outstanding, Diluted for 2022 was 32.5M shares.
Weighted Average Number of Shares Outstanding, Diluted, Annual (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Annual Growth (%)